{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:46:13Z","timestamp":1793893573316,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.phymed.2024.155398","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T19:03:23Z","timestamp":1708715003000},"page":"155398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial"],"prefix":"10.1016","volume":"130","author":[{"given":"Qiaohong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaosong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2846-7895","authenticated-orcid":false,"given":"Houkai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2208-2882","authenticated-orcid":false,"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155398_bib0001","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2024.155398_bib0002","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155398_bib0003","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phymed.2024.155398_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105849","article-title":"Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis","volume":"172","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2024.155398_bib0005","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41467-022-29968-0","article-title":"A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.phymed.2024.155398_bib0006","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11684-021-0880-3","article-title":"Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight\/obese subjects with non-alcoholic fatty liver disease: a translational approach","volume":"16","author":"Dai","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.phymed.2024.155398_bib0007","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/ptr.6972","article-title":"Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: a randomized, double-blind clinical trial","volume":"35","author":"Darvish Damavandi","year":"2021","journal-title":"PhytOther Res."},{"issue":"11","key":"10.1016\/j.phymed.2024.155398_bib0008","first-page":"805","article-title":"The diagnosis and treatment of non-alcoholic fatty liver disease (2017 vision)","volume":"25","year":"2017","journal-title":"Chin. J. Integr. Trad. West Dig."},{"key":"10.1016\/j.phymed.2024.155398_bib0009","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature24661","article-title":"A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites","volume":"551","author":"Dodd","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2024.155398_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02663-22","article-title":"Identification of gut microbial lysine and histidine degradation and CYP-dependent metabolites as biomarkers of fatty liver disease","volume":"14","author":"Driuchina","year":"2023","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.phymed.2024.155398_bib0011","first-page":"163","article-title":"Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition","volume":"18","author":"Fan","year":"2010","journal-title":"Zhonghua Gan. Zang. Bing. Za Zhi."},{"issue":"15","key":"10.1016\/j.phymed.2024.155398_bib0012","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM196910092811503","article-title":"Plasma amino acid levels and insulin secretion in obesity","volume":"281","author":"Felig","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2024.155398_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/184358","article-title":"Qushi Huayu decoction inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in vivo and in vitro","volume":"2013","author":"Feng","year":"2013","journal-title":"Evid. Based. Complement. Alternat. Med."},{"issue":"10","key":"10.1016\/j.phymed.2024.155398_bib0014","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.cgh.2022.08.036","article-title":"Clinical utility of combined MRI-PDFF and ALT response in predicting histologic response in nonalcoholic fatty liver disease","volume":"21","author":"Huang","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2024.155398_bib0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.metabol.2015.01.008","article-title":"Effect of insulin sensitizer therapy on amino acids and their metabolites","volume":"64","author":"Irving","year":"2015","journal-title":"Metabolism."},{"key":"10.1016\/j.phymed.2024.155398_bib0016","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jgh.13058","article-title":"Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease","volume":"31","author":"Kapil","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2024.155398_bib0017","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155398_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2020.101259","article-title":"The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"41","author":"Kazemi","year":"2020","journal-title":"Complement. Ther. Clin. Pract."},{"key":"10.1016\/j.phymed.2024.155398_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153135","article-title":"Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway","volume":"66","author":"Leng","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155398_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.phymed.2024.155398_bib0021","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.tem.2020.02.012","article-title":"Gut microbial metabolites of aromatic amino acids as signals in host\u2013microbe interplay","volume":"31","author":"Liu","year":"2020","journal-title":"Trends. Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2024.155398_bib0022","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2024.155398_bib0023","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jpba.2016.05.039","article-title":"Validation of UHPLC\u2013MS\/MS methods for the determination of kaempferol and its metabolite 4-hydroxyphenyl acetic acid, and application to in vitro blood-brain barrier and intestinal drug permeability studies","volume":"128","author":"Moradi-Afrapoli","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phymed.2024.155398_bib0024","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"issue":"48","key":"10.1016\/j.phymed.2024.155398_bib0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202934119","article-title":"A gut microbial metabolite of dietary polyphenols reverses obesity-driven hepatic steatosis","volume":"119","author":"Osborn","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U S. A."},{"key":"10.1016\/j.phymed.2024.155398_bib0026","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-Gomez","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155398_bib0027","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/mnfr.201200594","article-title":"Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein","volume":"57","author":"Russell","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phymed.2024.155398_bib0028","doi-asserted-by":"crossref","first-page":"106925","DOI":"10.1016\/j.phrs.2023.106925","article-title":"Natural products in non-alcoholic fatty liver disease (NAFLD): novel lead discovery for drug development","volume":"196","author":"Wang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2024.155398_bib0029","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.freeradbiomed.2020.04.013","article-title":"Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota","volume":"156","author":"Wang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phymed.2024.155398_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2024.155398_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2024.155398_bib0032","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155398_bib0033","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.2147\/DMSO.S332659","article-title":"QSHY granules promote white adipose tissue browning and correct BCAAs metabolic disorder in NAFLD mice","volume":"14","author":"Zhang","year":"2021","journal-title":"Diabetes. Metab. Syndr. Obes."},{"key":"10.1016\/j.phymed.2024.155398_bib0034","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T01:16:22Z","timestamp":1717463782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":34,"alternative-id":["S0944711324000631"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155398","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155398"}}